Data / Form D filings / JJ PHARMA INC
JJ PHARMA INC: Form D filings
JJ PHARMA INC, a pharmaceuticals company in San Francisco, CA, filed 2 Form D notices with the SEC in 2009. The latest, on December 16, 2009, reports $255,002 sold of a $255,002 offering to 8 investors.
Find out what JJ PHARMA INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 505 MONTGOMERY STREET; 10TH FLOOR, San Francisco, CA, 94111
- Phone
- (415) 874-3047
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- California
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1387599
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 16, 2009 | Amendment | $255,002 | $255,002 | $0 | 8 | Sep 5, 2009 | sec.gov |
| Sep 21, 2009 | New notice | $70,001 | $70,001 | $0 | 3 | Sep 5, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Peter Colella | Executive Officer, Director | |
| Rom Eliaz | Executive Officer, Director | |
| Ki Ingersol | Executive Officer, Director | |
| Wayne Hamersly | Director | |
| Denis Burger | Director | |
| Gleason Eakin | Director | |
| Josefino Tunac | Executive Officer |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Dec 14, 2009 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what JJ PHARMA INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.